A groundbreaking study has identified two early warning signs of Parkinson’s disease that may manifest ‘up to five years’ before an official diagnosis is made. Parkinson’s disease, a debilitating neurological condition that predominantly affects the muscles and skeletal system, has been found to exhibit lesser-known signs such as hearing loss and epilepsy as early indicators of the disease.
The research, published in JAMA Neurology in 2022, analysed medical records from over one million people to uncover these early symptoms of Parkinson’s disease. Conducted by Queen Mary University of London, the study aimed to provide a comprehensive understanding of the ailment’s impact on individuals, regardless of ethnicity or socio-economic status.
The study focused on East London residents from 1990 to 2018, a community characterised by high socio-economic deprivation and diverse ethnic backgrounds. It unearthed a potential link between epilepsy and an increased risk of Parkinson’s disease later in life. Moreover, the study highlighted hearing loss as a possible early indicator, which may appear up to five years before an official diagnosis of Parkinson’s.
Lead author of the study, Cristina Simonet, MD, emphasised the importance of primary care practitioners being vigilant about these early signs to ensure timely diagnoses for patients. The researchers underscored the need for further investigation into the relationship between hearing loss and Parkinson’s disease, suggesting that sensory impairment could play a role in the disease’s development.
Additionally, the study revealed new patterns within well-known Parkinson’s symptoms, such as tremors appearing up to ten years before diagnosis and memory issues emerging up to five years prior to an official diagnosis. The research also identified associations between Parkinson’s disease and conditions like low blood pressure, high blood pressure, and type two diabetes.
The findings shed light on the complexity of Parkinson’s disease and highlight the importance of early detection and intervention. By recognising these early warning signs, healthcare professionals can potentially improve outcomes for individuals affected by the condition.
In conclusion, the study offers valuable insights into the early manifestations of Parkinson’s disease, paving the way for enhanced diagnosis and treatment strategies. By identifying these warning signs, healthcare providers can intervene sooner, potentially improving the quality of life for those living with Parkinson’s disease.